Nuvo Research, Ranbaxy signs deal to market Oxoferin in Asian countries
Friday, November 13, 2009 17:00 IST Our Bureau, Mumbai
The Canada-based transdermal drug development firm Nuvo Research Inc and Daiichi-Ranbaxy, the Indian subsidiary of Japanese drug major Daiichi Sankyo has entered into an exclusive license agreement